What is US Ophthalmic?
Founded in 1992 and headquartered in Miami, Florida, US Ophthalmic operates as a critical wholesaler and distributor of high-precision ophthalmic goods. The company maintains a comprehensive product ecosystem that includes diagnostic tools, slit lamps, tomography systems, and advanced lens drilling machinery. By providing essential medical furniture and finishing equipment, US Ophthalmic acts as a foundational partner for clinical practices and surgical centers, ensuring that practitioners have access to the hardware necessary for high-quality patient care. Their long-standing presence in the industry has allowed them to build a robust supply chain that bridges the gap between global manufacturers and domestic healthcare providers.
How much funding has US Ophthalmic raised?
US Ophthalmic has raised a total of $344K across 2 funding rounds:
Debt
$150K
Debt
$194K
Debt (2020): $150K with participation from PPP
Debt (2021): $194K led by PPP
Key Investors in US Ophthalmic
PPP
Public-Private Partnership
What's next for US Ophthalmic?
With the successful acquisition of $194K, US Ophthalmic is well-positioned to optimize its logistics infrastructure and expand its footprint in the competitive medical equipment distribution landscape. The strategic focus will likely shift toward integrating next-generation diagnostic technologies into their existing catalog and enhancing service capabilities for their clinical client base. As the company navigates the complexities of the late-stage growth phase, the emphasis remains on maintaining operational efficiency and leveraging their established market presence to capture additional share in the ophthalmic technology sector. Future initiatives may include the diversification of their product offerings to address emerging trends in digital tomography and automated lens processing, ensuring long-term relevance in a rapidly evolving healthcare market.
See full US Ophthalmic company page
